The use of adenoviral vectors in gene therapy and vaccine approaches
Abstract Adenovirus was first identified in the 1950s and since then this pathogenic group of viruses has been explored and transformed into a genetic transfer vehicle. Modification or deletion of few genes are necessary to transform it into a conditionally or non-replicative vector, creating a vers...
Հիմնական հեղինակներ: | Natália Meneses Araújo, Ileana Gabriela Sanchez Rubio, Nicholas Pietro Agulha Toneto, Mirian Galliote Morale, Rodrigo Esaki Tamura |
---|---|
Ձևաչափ: | Հոդված |
Լեզու: | English |
Հրապարակվել է: |
Sociedade Brasileira de Genética
2022-10-01
|
Շարք: | Genetics and Molecular Biology |
Խորագրեր: | |
Առցանց հասանելիություն: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1415-47572022000400108&tlng=en |
Նմանատիպ նյութեր
-
Development of novel vaccine vectors: Chimpanzee adenoviral vectors
: Jingao Guo, և այլն
Հրապարակվել է: (2018-07-01) -
Factors Which Contribute to the Immunogenicity of Non-replicating Adenoviral Vectored Vaccines
: Lynda Coughlan
Հրապարակվել է: (2020-05-01) -
Advances of Recombinant Adenoviral Vectors in Preclinical and Clinical Applications
: Luca Scarsella, և այլն
Հրապարակվել է: (2024-02-01) -
Improving adenoviral vectors and strategies for prostate cancer gene therapy
: Rodrigo Esaki Tamura, և այլն
Հրապարակվել է: (2018-08-01) -
DEVELOPMENT OF VACCINES BASED ON ADENOVIRAL VECTORS: A REVIEW OF FOREIGN CLINICAL STUDIES (PART 2)
: L. V. Cherenova, և այլն
Հրապարակվել է: (2017-08-01)